Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis.

MLA

Kontzias, Christina L., et al. “Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis.” Journal of Drugs in Dermatology : JDD, vol. 22, no. 7, July 2023, pp. 668–72. EBSCOhost, https://doi.org/10.36849/JDD.7497.

APA

Kontzias, C. L., Curcio, A., Gorodokin, B., Tissera, K. A., Feldman, S. R., Bhatia, N., Callender, V. D., & Kircik, L. (2023). Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis. Journal of Drugs in Dermatology : JDD, 22(7), 668–672. https://doi.org/10.36849/JDD.7497

Chicago

Kontzias, Christina L, Alyssa Curcio, Brandon Gorodokin, Kristin A Tissera, Steven R Feldman, Neal Bhatia, Valerie D Callender, and Leon Kircik. 2023. “Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis.” Journal of Drugs in Dermatology : JDD 22 (7): 668–72. doi:10.36849/JDD.7497.